JOHNSON KENNETH ERLAND (See Remarks) received a stock award from XERIS PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/1/2021ACC: 0001346302-21-000010
Officer· See Remarks
Since Jan 2019
+65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
65K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+65K
Price / share
—
Trade value
—
% of position
241.7%
1/29/2021
26.89K→91.89K
Total
Net shares
+65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2021 | A · Award | +65K | — | — | 241.7% | 26.89K | 91.89K |
| Total | +65K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported